Role of the hospital pharmacy and therapeutics committee in detecting and regulating off-label drug use, reply to letter

  • Esther Duran-GarciaEmail author
  • Bernardo Santos-Ramos
  • Francesc Puigventós-Latorre
  • Ana Ortega
Letter to the Editor


Regulatory Agency Evaluation Report Hospital Pharmacy Hospital Level Scientific Support 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Durán-García E, Santos-Ramos B, Puigventos-Latorre F, Ortega A. Literature review on the structure and operation of pharmacy and therapeutics committees. Int J Clin Pharm. 2011;33:475–83.PubMedCrossRefGoogle Scholar
  2. 2.
    Delgado O, Puigventós F, Clopés A. Position of the hospital pharmacist regarding the use of medication in non-authorised conditions. Farm Hosp. 2009;33:237–239, Spanish.Google Scholar
  3. 3.
    Puigventós F, Santos-Ramos B, Ortega A, Durán-García E. Structure and procedures of the pharmacy and therapeutic committees in Spanish hospitals. Pharm World Sci. 2010;32:767–75.PubMedCrossRefGoogle Scholar
  4. 4.
    Group for Innovation, Assessment, Standardisation and Research in the Selection of Drugs of the Spanish Society of Hospital Pharmacy. Drug use in conditions other than those authorized in data sheet. Accessed 31 May 2011.
  5. 5.
    de Vries TPGM, Henning RH, Hogerzeil HV, Fresle DA. Guide to good prescribing. A practical manual. World Health Organization ed. Geneve; 1994.Google Scholar

Copyright information

© Springer Science+Business Media B.V. 2011

Authors and Affiliations

  • Esther Duran-Garcia
    • 1
    Email author
  • Bernardo Santos-Ramos
    • 1
  • Francesc Puigventós-Latorre
    • 1
  • Ana Ortega
    • 1
  1. 1.Hospital General Universitario Gregorio MarañonMadridSpain

Personalised recommendations